Journal of Jilin University(Medicine Edition) ›› 2022, Vol. 48 ›› Issue (4): 1071-1078.doi: 10.13481/j.1671-587X.20220431
• Review • Previous Articles
Research progress in regulatory effect of intestinal microecology on intestinal immune homeostasis and epigenetic modification and its relationship with occurrence and development of colorectal cancer
-
Received:2021-08-20Online:2022-07-28Published:2022-07-26
CLC Number:
- R735.35
Cite this article
share this article
| 1 | JEON J， DU M M， SCHOEN R E， et al. Determining risk of colorectal cancer and starting age of screening based on lifestyle， environmental， and genetic factors［J］. Gastroenterology， 2018，154（8）：2152-2164.e19. |
| 2 | SUNG H， FERLAY J， SIEGEL R L， et al. Global cancer statistics 2020： GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］. CA Cancer J Clin， 2021， 71（3）： 209-249. |
| 3 | AKIMOTO N， UGAI T， ZHONG R， et al. Rising incidence of early-onset colorectal cancer-a call to action［J］. Nat Rev Clin Oncol， 2021， 18（4）： 230-243. |
| 4 | ESPENSCHIED C R， LADUCA H， LI S W， et al. Multigene panel testing provides a new perspective on lynch syndrome［J］. J Clin Oncol， 2017， 35（22）： 2568-2575. |
| 5 | SHAH R S， PLESEC T， BHATT A. Abnormal biliary mucosa uncovered in a familial adenomatous polyposis patient［J］. Gastroenterology， 2020， 158（5）： e1-e2. |
| 6 | SENGUPTA S， BOSE S. Peutz-jeghers syndrome［J］. N Engl J Med，2019，380（5）：472. |
| 7 | BARREAU F， TISSEYRE C， MÉNARD S， et al. Titanium dioxide particles from the diet： involvement in the genesis of inflammatory bowel diseases and colorectal cancer［J］. Part Fibre Toxicol， 2021， 18（1）： 26. |
| 8 | HONG S N. Genetic and epigenetic alterations of colorectal cancer［J］. Intest Res， 2018， 16（3）： 327-337. |
| 9 | WILD C P. Complementing the genome with an “exposome”： the outstanding challenge of environmental exposure measurement in molecular epidemiology［J］. Cancer Epidemiol Biomarkers Prev， 2005， 14（8）： 1847-1850. |
| 10 | ZHAO Y H， WANG C X， GOEL A. Role of gut microbiota in epigenetic regulation of colorectal cancer［J］. Biochim Biophys Acta Rev Cancer，2021， 1875（1）： 188490. |
| 11 | HOLLISTER E B， GAO C X， VERSALOVIC J. Compositional and functional features of the gastrointestinal microbiome and their effects on human health［J］. Gastroenterology， 2014， 146（6）： 1449-1458. |
| 12 | BELKAID Y， HARRISON O J. Homeostatic immunity and the microbiota［J］. Immunity，2017，46（4）： 562-576. |
| 13 | WEYRICH A， LENZ D， FICKEL J. Environmental change-dependent inherited epigenetic response［J］. Genes （Basel）， 2018， 10（1）： E4. |
| 14 | WEYRICH A， YASAR S， LENZ D， et al. Tissue-specific epigenetic inheritance after paternal heat exposure in male wild Guinea pigs［J］. Mamm Genome， 2020， 31（5/6）： 157-169. |
| 15 | WU J M， ZHAO Y， WANG X， et al. Dietary nutrients shape gut microbes and intestinal mucosa via epigenetic modifications［J］. Crit Rev Food Sci Nutr， 2022，62（3）： 783-797. |
| 16 | DOVE W F， CLIPSON L， GOULD K A， et al. Intestinal neoplasia in the ApcMin mouse： independence from the microbial and natural killer （beige locus） status［J］. Cancer Res， 1997， 57（5）： 812-814. |
| 17 | FENG Q， LIANG S S， JIA H J， et al. Gut microbiome development along the colorectal adenoma-carcinoma sequence［J］. Nat Commun， 2015， 6： 6528. |
| 18 | DAI Z W， COKER O O， NAKATSU G， et al. Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers［J］. Microbiome，2018，6（1）： 70. |
| 19 | YU J， FENG Q， WONG S H， et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer［J］. Gut， 2017， 66（1）： 70-78. |
| 20 | NAKATSU G， LI X C， ZHOU H K， et al. Gut mucosal microbiome across stages of colorectal carcinogenesis［J］. Nat Commun， 2015， 6： 8727. |
| 21 | GALLOWAY-PEÑA J R， SMITH D P， SAHASRABHOJANE P， et al. Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients［J］. Genome Med， 2017， 9（1）： 21. |
| 22 | GHOSH T S， DAS M， JEFFERY I B， et al. Adjusting for age improves identification of gut microbiome alterations in multiple diseases［J］.Elife，2020，9： e50240. |
| 23 | MIZUTANI S， YAMADA T， YACHIDA S. Significance of the gut microbiome in multistep colorectal carcinogenesis［J］. Cancer Sci， 2020， 111（3）： 766-773. |
| 24 | STRACHAN D P. Hay fever， hygiene， and household size［J］. BMJ， 1989， 299（6710）： 1259-1260. |
| 25 | KOLIARAKIS I， PSAROULAKI A， NIKOLOUZAKIS T K， et al. Intestinal microbiota and colorectal cancer： a new aspect of research［J］. J BUON， 2018， 23（5）： 1216-1234. |
| 26 | KOULOURIS A， TSAGKARIS C， MESSARITAKIS I， et al. Resectable colorectal cancer： current perceptions on the correlation of recurrence risk， microbiota and detection of genetic mutations in liquid biopsies［J］. Cancers， 2021， 13（14）： 3522. |
| 27 | TOJO R， SUÁREZ A， CLEMENTE M G， et al. Intestinal microbiota in health and disease： role of bifidobacteria in gut homeostasis［J］. World J Gastroenterol， 2014， 20（41）： 15163-15176. |
| 28 | GOGOKHIA L， BUHRKE K， BELL R， et al. Expansion of bacteriophages is linked to aggravated intestinal inflammation and colitis［J］. Cell Host Microbe， 2019， 25（2）： 285-299.e8. |
| 29 | CHENG A S L， LI M S， KANG W， et al. Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis［J］. Gastroenterology， 2013， 144（1）： 122-133.e9. |
| 30 | NAKATA K， SUGI Y， NARABAYASHI H， et al. Commensal microbiota-induced microRNA modulates intestinal epithelial permeability through the small GTPase ARF4［J］. J Biol Chem， 2017， 292（37）： 15426-15433. |
| 31 | LIANG L X， AI L Y， QIAN J， et al. Long noncoding RNA expression profiles in gut tissues constitute molecular signatures that reflect the types of microbes［J］. Sci Rep， 2015， 5： 11763. |
| 32 | MOLONEY G M， VIOLA M F， HOBAN A E， et al. Faecal microRNAs： indicators of imbalance at the host-microbe interface？ ［J］. Benef Microbes， 2018， 9（2）： 175-183. |
| 33 | KOSTIC A D， GEVERS D， PEDAMALLU C S，et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma［J］.Genome Res，2012，22（2）： 292-298. |
| 34 | LI Y Y， GE Q X， CAO J， et al. Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients［J］. World J Gastroenterol， 2016， 22（11）： 3227-3233. |
| 35 | SUEHIRO Y， SAKAI K H， NISHIOKA M， et al. Highly sensitive stool DNA testing of Fusobacterium nucleatum as a marker for detection of colorectal tumours in a Japanese population［J］. Ann Clin Biochem， 2017， 54（1）： 86-91. |
| 36 | OH H J， KIM J H， BAE J M， et al. Prognostic impact of fusobacterium nucleatum depends on combined tumor location and microsatellite instability status in stage Ⅱ/Ⅲ colorectal cancers treated with adjuvant chemotherapy［J］. J Pathol Transl Med， 2019， 53（1）： 40-49. |
| 37 | SUN C H， LI B B， WANG B， et al. The role of Fusobacterium nucleatum in colorectal cancer： from carcinogenesis to clinical management［J］. Chronic Dis Transl Med， 2019， 5（3）： 178-187. |
| 38 | KOMIYA Y， SHIMOMURA Y， HIGURASHI T，et al. Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity［J］. Gut， 2019， 68（7）： 1335-1337. |
| 39 | HALE V L， CHEN J， JOHNSON S， et al. Shifts in the fecal microbiota associated with adenomatous polyps［J］. Cancer Epidemiol Biomarkers Prev， 2017， 26（1）： 85-94. |
| 40 | DREWES J L， CORONA A， SANCHEZ U， et al. Transmission and clearance of potential procarcinogenic bacteria during fecal microbiota transplantation for recurrent Clostridioides difficile［J］. JCI Insight， 2019， 4（19）： e130848. |
| 41 | NAKATSU G， ZHOU H K， WU W K K， et al. Alterations in enteric virome are associated with colorectal cancer and survival outcomes［J］. Gastroenterology， 2018， 155（2）： 529-541.e5. |
| 42 | BOLEIJ A， MVAN GELDER M， SWINKELS D W， et al. Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients： systematic review and meta-analysis［J］.Clin Infect Dis，2011，53（9）： 870-878. |
| 43 | BODAGHI S， YAMANEGI K， XIAO S Y， et al. Colorectal papillomavirus infection in patients with colorectal cancer［J］. Clin Cancer Res， 2005， 11（8）： 2862-2867. |
| 44 | KOSTIC A D， CHUN E， ROBERTSON L， et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment［J］. Cell Host Microbe， 2013，14（2）： 207-215. |
| 45 | KASHANI N， BEZMIN ABADI A T， RAHIMI F，et al.FadA-positive Fusobacterium nucleatum is prevalent in biopsy specimens of Iranian patients with colorectal cancer［J］. New Microbes New Infect， 2020， 34： 100651. |
| 46 | RANJBAR M， SALEHI R， HAGHJOOY JAVANMARD S， et al. The dysbiosis signature of Fusobacterium nucleatum in colorectal cancer-cause or consequences？ A systematic review［J］. Cancer Cell Int， 2021， 21（1）： 194. |
| 47 | RUBINSTEIN M R， WANG X W， LIU W， et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin［J］. Cell Host Microbe， 2013， 14（2）： 195-206. |
| 48 | KONG C， YAN X B， ZHU Y F， et al. Fusobacterium nucleatum promotes the development of colorectal cancer by activating a cytochrome P450/epoxyoctadecenoic acid axis via TLR4/Keap1/NRF2 signaling［J］. Cancer Res， 2021， 81（17）： 4485-4498. |
| 49 | YAN X B， LIU L G， LI H， et al. Clinical significance of Fusobacterium nucleatum， epithelial-mesenchymal transition， and cancer stem cell markers in stage Ⅲ/Ⅳ colorectal cancer patients［J］. Onco Targets Ther， 2017， 10： 5031-5046. |
| 50 | PROENÇA M A， BISELLI J M， SUCCI M， et al. Relationship between Fusobacterium nucleatum， inflammatory mediators and microRNAs in colorectal carcinogenesis［J］.World J Gastroenterol，2018，24（47）： 5351-5365. |
| 51 | CHEN T， LI Q， WU J， et al. Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism［J］. Cancer Immunol Immunother， 2018， 67（10）： 1635-1646. |
| 52 | HU L J， LIU Y， KONG X H， et al. Fusobacterium nucleatum facilitates M2 macrophage polarization and colorectal carcinoma progression by activating TLR4/NF-κB/S100A9 cascade［J］. Front Immunol， 2021， 12： 658681. |
| 53 | KORDAHI M C， STANAWAY I B， AVRIL M， et al. Genomic and functional characterization of a mucosal symbiont involved in early-stage colorectal cancer［J］. Cell Host Microbe， 2021， 29（10）： 1589-1598.e6. |
| 54 | LONG X H， WONG C C， TONG L， et al. Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity［J］. Nat Microbiol， 2019， 4（12）： 2319-2330. |
| 55 | TSOI H， CHU E S H， ZHANG X， et al. Peptostreptococcus anaerobius induces intracellular cholesterol biosynthesis in colon cells to induce proliferation and causes dysplasia in mice［J］. Gastroenterology， 2017， 152（6）： 1419-1433.e5. |
| 56 | SABIT H， CEVIK E， TOMBULOGLU H. Colorectal cancer： the epigenetic role of microbiome［J］. World J Clin Cases， 2019， 7（22）： 3683-3697. |
| 57 | GOMES S D， OLIVEIRA C S， AZEVEDO-SILVA J， et al. The role of diet related short-chain fatty acids in colorectal cancer metabolism and survival： prevention and therapeutic implications［J］. Curr Med Chem， 2020， 27（24）： 4087-4108. |
| 58 | YANG J， YU J. The association of diet， gut microbiota and colorectal cancer： what we eat may imply what we get［J］. Protein Cell， 2018， 9（5）： 474-487. |
| 59 | MA H， YU Y， WANG M M， et al. Correlation between microbes and colorectal cancer： tumor apoptosis is induced by sitosterols through promoting gut microbiota to produce short-chain fatty acids［J］. Apoptosis， 2019， 24（1/2）： 168-183. |
| 60 | WANG G， YU Y， WANG Y Z， et al. Role of SCFAs in gut microbiome and glycolysis for colorectal cancer therapy［J］. J Cell Physiol， 2019， 234（10）： 17023-17049. |
| 61 | FANG Y K， YAN C， ZHAO Q， et al. The roles of microbial products in the development of colorectal cancer：a review［J］.Bioengineered，2021，12（1）：720-735. |
| 62 | JIA W， XIE G X， JIA W P. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis［J］. Nat Rev Gastroenterol Hepatol， 2018， 15（2）： 111-128. |
| 63 | LIU T Y， SONG X L， KHAN S， et al. The gut microbiota at the intersection of bile acids and intestinal carcinogenesis： an old story， yet mesmerizing［J］. Int J Cancer， 2020， 146（7）： 1780-1790. |
| 64 | DALAL N， JALANDRA R， BAYAL N， et al. Gut microbiota-derived metabolites in CRC progression and causation［J］. J Cancer Res Clin Oncol， 2021， 147（11）： 3141-3155. |
| 65 | CHATTOPADHYAY I， DHAR R， PETHUSAMY K，et al. Exploring the role of gut microbiome in colon cancer［J］. Appl Biochem Biotechnol， 2021， 193（6）： 1780-1799. |
| [1] | Qian LIU,Guoping QI,Huayi YU,Yuyang DAI,Wenbin LU,Jianhua JIN. Bioinformatics analysis on screening of colon cancer core genes and independent prognostic factors [J]. Journal of Jilin University(Medicine Edition), 2022, 48(3): 755-765. |
| [2] | Suxian CHEN,Zehui GU,Yangfei MA,Qi TAN,Qi LI,Yadi WANG. Promotion effect of rutin on apoptosis of human colon cancer SW480 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2022, 48(2): 356-363. |
| [3] | Lili HUANG,Yuxuan LIU,Kaiyi FANG,Yeteng MU,Nannan HU,Chong GUO,Fuxu YANF,Xingang GUAN. Preparation of oxaliplatin-loaded cell membrane nanodrugs and its killing effect on colon cancer cells of mice [J]. Journal of Jilin University(Medicine Edition), 2021, 47(6): 1422-1428. |
| [4] | Bo MA, Jiangang LI, Jun WANG, Junli HOU, Liang LI. Promotion effect of miR-106b on invasion and migration of colon cancer cells through targeting TGF-β/Smad pathway [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 630-636. |
| [5] | Xiaohui LI, Ziwei QU, Xin LU, Qingbin MENG, Huatao CHEN, Jun REN, Chengpei TAN. Regulatory effect of exosomes carrying miR-196b-5p derived from bone marrow mesenchymal stem cells on biological characteristics of colon cancer cells [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 660-668. |
| [6] | Xia LI,Yi YU,Haiwei ZUO,Fengjuan ZHOU,Yong XIN. Inhibitory effect of circRNA on colorectal cancer and its bioinformatics analysis [J]. Journal of Jilin University(Medicine Edition), 2020, 46(6): 1283-1287. |
| [7] | YAN Shengyu, XIE Yafeng, XU Zhijie, LIU Ying, DING Yating, ZHANG Qiao, LIU Wanying, LIU Libing. Inhibitory effect of antimicrobial peptide LL-37 on tumorgrowth of mice with colon cancer and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2020, 46(03): 575-581. |
| [8] | FENG Jie, REN Liqun, CHEN Suxian, WAN Yizeng, XU Peibin. Inhibitory effects of cucurbitacin B combined with oxaliplatin on proliferation and apoptosis of human colon cancer SW480 cells and their mechanisms [J]. Journal of Jilin University(Medicine Edition), 2020, 46(01): 78-83. |
| [9] | LI Hua, CAO Yansha, ZHAO Jinping, REN Fu, LI Ning. Expression of SIRT6 protein in colon cancer tissue detected by tissue microarray technique and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2019, 45(04): 893-898. |
| [10] | WANG Dan, SONG Ziqi, LI Yifei, LI Chun, DONG Zhiheng, DONG Ying, GAI Xiaodong. Expressions of Foxp3+ regulatory T cells and myeloid dentritic cells in human colorectal cancer and tumor draining lymph node tissues and their significances [J]. Journal of Jilin University(Medicine Edition), 2019, 45(03): 621-626. |
| [11] | YANG Xueliang, WANG Minghua, LIU Yanbo, SUN Xuemei, ZHAO Xiahui, YANG Lijuan, XIAO Zishen. Effect of recombinant human IL-17A on growth of colon cancer cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2019, 45(02): 258-261. |
| [12] | WANG Tinggang, XUE Feng, LI Yu, NIU Zhaojian, WANG Ye. Effects of miR-26a targeting HMGA1 gene on growth, invasion and migration of colon cancer cells [J]. Journal of Jilin University(Medicine Edition), 2018, 44(06): 1205-1211. |
| [13] | WANG Dan, LI Yifei, LI Chun, DONG Zhiheng, DONG Ying, GAI Xiaodong. Relationships between expressions of B7-H1 and B7-H4 and Foxp3+ regulated T-cell infiltration in colorectal cancer tissue [J]. Journal of Jilin University Medicine Edition, 2018, 44(03): 543-547. |
| [14] | YANG Xueliang, SUN Xuemei, ZHAO Xiaohui, YANG Lijuan, SHEN Weigao, XIAO Zishen, GUO Chong, LIU Yanbo. Expressions of IL-17E, IL-17F and their receptors in colorectal carcinoma tissue and their significances [J]. Journal of Jilin University Medicine Edition, 2018, 44(03): 574-578. |
| [15] | CAO Yansha, LI Hua, CHEN Minghong, LIU Baoqin, WANG Huaqin, LI Ning. Expression of BAG3 protein in colon cancer tissue detected by tissue microarray method and its clinical significance [J]. Journal of Jilin University Medicine Edition, 2017, 43(06): 1177-1181. |
|
||